We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.
Showing 1 out of 1
Marc A. Riedl, Emel Aygören-Pürsün, William R. Lumry, Henriette Farkas, Andrea Zanichelli, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Jonathan A. Bernstein, Marcus Maurer, Danny M. Cohn